key: cord-0970144-gqqhhhlr authors: Bhat, Vedika; Borse, Swapnil; Chavan-Gautam, Preeti; Joshi, Kalpana title: Exploring AyuGenomics approach for understanding COVID-19 predisposition and progression date: 2021-06-17 journal: J Ayurveda Integr Med DOI: 10.1016/j.jaim.2021.06.003 sha: 4171b6585dda4fe7b462f16d23102bde581139ae doc_id: 970144 cord_uid: gqqhhhlr Recent reports on COVID-19 suggest, the susceptibility to COVID-19 and its progression have a genetic predisposition. Majorly associated genetic variants are found in human leukocyte antigen (HLA), angiotensin convertase enzyme (ACE; rs1799752: ACE2; rs73635825), transmembrane protease serine 2 (TMPRSS-2; rs12329760) genes. Identifying highly prone population having these variants is imperative for determining COVID-19 therapeutic strategy. Ayurveda (Indian traditional system of medicine) concept of Prakriti holds potential to predict genomic and phenotypic variations. Reported work on Prakriti correlates HLA-DR alleles with three broad phenotypes (Tridosha) described in Ayurveda (AyuGenomics). This is suggestive of differences in immune responses in individuals with specific constitutions. Therefore, the reported studies provide clues for clinically relevant hypotheses to be tested in systematic studies. The proposed approach of Ayurveda based phenotype screening may offer a way ahead to design customized strategies for management of COVID-19 based on differences in Prakriti, immune response and drug response. However, this needs clinical evaluation of the relation between Prakriti and genetic or phenotypic variants in COVID-19 prone and resistant populations. The COVID-19, novel coronavirus disease has emerged as a global pandemic challenge. The global mortality and morbidity with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an unprecedented public health emergency.(1, 2) Continuously evolving statistics suggests an estimated overall COVID-19 mortality of 0.25-3.0% among the infected population. (3) The worldwide data has shown that co-morbidity such as obesity, hypertension, diabetes, coronary heart diseases and cerebrovascular disease act as risk factors for COVID -19 with increased risk of mortality. (4) The mortality is more than 14% among elderly (over 80 years), 10% in associated cardiovascular diseases (CVD) and 7% in associated diabetes. (5) The SARS-CoV-2 is novel +ssRNA virus which enters the human body through binding and priming of viral spike (S) protein with the human Angiotensin Converting Enzyme 2 (ACE 2) receptor and a protease Transmembrane Serine Protease 2 (TMPRSS 2) respectively. (6) The virus has an average incubation period of 5-6 days, however in some cases it can be up to 14 days. (7) The SARS-CoV-2infection manifests itself through a wide range of disease presentation. It ranges from asymptomatic COVID-19 to mild cases or to severe form leading to death. Individualized phenotypic characteristics play an important role in understanding the interindividual variability in disease susceptibility and prognosis. The study of these phenotypic variations associated with differences in genetic patterns seems promising for achieving different objectives such as, identifying high risk and disease resistant population as well as providing individualized pharmacotherapeutic management. (8) The traditional medicinal systems such as, Ayurveda, Traditional Chinese Medicine, Tibetan Medicine, and Korean Medicine have well defined systems of constitutional types. They have J o u r n a l P r e -p r o o f personalized approaches for predicting disease predisposition and progression based on their fundamental theories. (9) AyuGenomics is one such approaches that is based on integration of Ayurveda and modern genomics.(10) It presents an example of Integrative Medicine where conventional physiology meets ancient concept of phenotypic classifications. Ayurveda defines health as a state of physical, psychological, social and spiritual well-being. It is based on important doctrines such as theory of Panchamahabhoota (the five basic elements -Space, Air, Fire, Water and Earth). Properties of Aatma(~Soul) called trigunas (psychological qualities -Satwa, Rajas, Tamas) interact with panchamahabhutas leading to representation of typical phenotypes called Doshas (three key biological humors -Vata, Pitta andKapha). (|| Ashtanga Hridaya, Sutra Sthana 1 ||). In Ayurvedic philosophy, these three Doshas, are believed to determine the unique combination of physical, physiological, and psychological features of an individual. The Prakriti of a person is a consequence of the relative proportions of these three Doshas (11) (12) (13) . According to Ayurveda, prakriti is the inherent constitution of an individual established at the time of conception and distinguishes variations, into three broad phenotype categories termed as tridosha, namely-Vata(V),Pitta(P) and Kapha(K). (14) Each of this dosha is believed to regulate specific physiological process. For example, V is responsible for movements; P governs energy while K regulates lubrication, cohesion and structure. It has been stated that doshas are fundamental to all living systems and organisms at all levels of biological organization ranging from a single cell to the whole body. Genomics is the study of the full genetic complement of an organism (the genome) (31) . Pharmacogenomics is the study of how human genetic information impacts drug response, and it aims to improve efficacy and reduce side effects (32) . Phenomics connects Omics data with phenotypes, but the current status of phenomics or pharmacophenomics is still unable to reach bed side from bench research. Whereas, Ayurveda, understands the individualized phenotype to the very deep level with due consideration of all the possible confounding environmental factors for genotype to phenotype map (33) . In order to understand exact clinical phenotypes, Ayurveda has clinically validated system of phenotypic prediction with respect to individualized disease state (29, 34) . Thereby, AyuGenomics connects Genomics with Ayurvedic phenotypic approach for predicting disease susceptibility, prognosis as well as therapeutic effectiveness. Developing predictive markers for high-risk individuals; identifying the determinants leading to concept, has previously shown association between EGLN-1 polymorphism, prakriti phenotypes, high altitude adaption and susceptibility towards high altitude pulmonary edema (HAPE). As per this, K prakriti individuals may be at higher risk for HAPE while P prakriti individuals may be more protected. (29) Human variations related to immune response and its relation with prakriti and disease susceptibility is well-documented in Ayurveda. According to this, order of eliciting J o u r n a l P r e -p r o o f immune response in different prakriti individuals is K > P >V. (39) . A study showing, differential expression of CD markers according to prakriti is a proof of concept for variable immune response among constitution types. (40) According to this study, significant difference (P< 0.05) was observed in the expression of innate and adaptive immunity specific CD markers such as CD14 (monocytes), CD25 (activated B cells) and CD56 (Natural killer cells) among different prakriti groups. CD25 and CD56 expression was significantly higher in K prakriti samples than other prakriti groups. Similarly, slightly higher levels of CD14 were observed in P prakriti samples.Xie et al. reported, direct correlation between levels of soluble CD25 (sCD25) and severity of COVID-19.Study discovered, elevation of sCD25 leads to expansion of CD25 + PD-1 + CD8 + T cells enhancing proinflammatory immune response rather than anti-viral immune response aggravating disease severity (High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses (41) . Another study reported robust NK cell response and some characteristic findings in advanced stage patients. According to this, arming of cytotoxic molecules like perforin with effector NK cell phenotype CD56 bright is associated with COVID-19 severity (42) . Therefore, it will be very interesting to study the prakriti specific immune profile of COVID-19 patients. Ayurveda literature extensively describes phenotypic determinants of prakriti types. They form a noninvasive, robust, simple yet precise method to stratify individuals. Along with this, identifying prakriti specific gene markers may facilitate sub-grouping of COVID-19 patients. (40) Table 1 summarizes the possible hypotheses which can be studied for understanding COVID-19 susceptibility, symptoms, prognosis and therapy based on existing AyuGenomics reports. J o u r n a l P r e -p r o o f Patients infected with SARS-CoV-2 present a heterogeneous course of symptoms and disease severity. Among the various confounding factors, host genetics may play a major role in disease progression(47) SARS-CoV-2 enters the host cell by binding of spike protein (S protein) S1 unit with human ACE-2 receptor present on target cells. Along with this, viral entry requires S protein priming by cellular protease TMPRSS2. This protease cleaves S protein at S1/S2 and S2' site enhancing the viral and cellular membrane fusion (6) . Other than lungs, the receptor is expressed in heart, brain, liver, pancreas, intestine, eyes, prostate, testis and placenta which explains multiple organ failure in COVID-19. (49, 50) The viral infection results into imbalance between ACE/ACE-2 and renin angiotensin aldosterone system (RAAS) activation. This process facilitates COVID-19 progression and is the cause of severe disease in comorbid patients (51) . Genetic polymorphisms in ACE and TMPRSS2 are likely to be associated with COVID-19 susceptibility and progression (52) . This might be a major factor responsible for ethnic and geographical variation between disease prevalence and severity (53) . respectively. Whereas, higher allele frequency of HLA DRB1*10 was found in the K than V and Prakriti. (25) Therefore, studying association of all these variants (table 2) Director-General's opening remarks at the media briefing on COVID-19 -11 COVID-19 Pandemic: A pragmatic plan for Ayurveda Intervention Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020. 7. WHO. Coronavirus disease (COVID-2019) What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective The scientific value of Ayurveda The quest for evidence-based Ayurveda: lessons learned Translating Ayurveda's Dosha-Prakriti into objective parameters Potential of ayurgenomics approach in complex trait research: Leads from a pilot study on rheumatoid arthritis FACTORS INFLUENCING PRAKRITI (CONSTITUTION) AND INFLUENCED BY PRAKRITI (CONSTITUTION) Chaukhamba Orientalia Ayurvedic physiology and etiology: Ayurvedo Amritanaam. The doshas and their functioning in terms of contemporary biology and physical chemistry Prakriti and its associations with metabolism, chronic diseases, and genotypes: possibilities of new born screening and a lifetime of personalized prevention Recapitulation of Ayurveda constitution types by machine learning of phenotypic traits Scientific validation of ayurvedic concept of prakriti (psycho-somatic constitution) -current evidences Ayurvedic concept of constitution) and variations in platelet aggregation. BMC complementary and alternative medicine Constitutional study of cancer patients-its prognostic and therapeutic scope. Ancient science of life Association of constitutional type of Ayurveda with cardiovascular risk factors, inflammatory markers and insulin resistance Concept of deha prakriti vis-à-vis human constitution in Ayurveda. Ancient science of life Ayurvedic genomics: establishing a genetic basis for mindbody typologies Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda Traditional medicine to modern pharmacogenomics: Ayurveda Prakriti type and CYP2C19 gene polymorphism associated with the metabolic variability. Evidence-Based Complementary and Alternative Medicine Potential of ayurgenomics approach in complex trait research: leads from a pilot study on rheumatoid arthritis EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda Association of Kaphaja and Kapha-Pittaja Prakriti and methylenetetrahydrofolate reductase C677T allele with type 2 diabetes Genomics for the world Phenomics: the next challenge Ayurvedic constitution (prakruti) identifies risk factor of developing Parkinson's disease Sharpening the global focus on ethnicity and race in the time of COVID-19. The Lancet Association between age and clinical characteristics and outcomes of COVID-19 Gender differences in patients with COVID-19: Focus on severity and mortality Does the pathogenesis of SAR-CoV-2 virus decrease at highaltitude? Charak sanhita Pune: Chaukhamba Immunophenotyping of normal individuals classified on the basis of human dosha prakriti High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses Natural killer cell immunotypes related to COVID-19 disease severity Ayurgenomics: a new way of threading molecular variability for stratified medicine Imbalanced host response to SARS-CoV-2 drives development of COVID-19 Biochemical and anthropometric profiles of different prakriti (Ayurvedic constitution) patients of non-insulin dependent diabetes mellitus Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19 The impact of hypoxia in hepatocellular carcinoma metastasis. Frontiers of medicine ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis HOW GENETICISTS CONTRIBUTE TO UNDERSTANDING OF COVID-19 DISEASE PATHOGENICITY Molecular immune pathogenesis and diagnosis of COVID-19 Immunobiology: the immune system in health and disease1999 Human leukocyte antigen susceptibility map for SARS-CoV-2 Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2) Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2 Imbalanced host response to SARS-CoV-2 drives development of COVID-19 Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village Clinical profile of covid-19 infected patients admitted in a tertiary care hospital in north India Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components Variation between populations in the innate immune response to vaccine adjuvants Integrative approaches for health: Biomedical research, Ayurveda and Yoga Anguli Parimana in Ayurveda and its association with adiposity and diabetes